Guggenheim Capital LLC grew its position in Healthpeak Properties (NASDAQ:PEAK) by 2.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 573,086 shares of the company’s stock after buying an additional 14,869 shares during the quarter. Guggenheim Capital LLC owned 0.11% of Healthpeak Properties worth $13,669,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of PEAK. Victory Capital Management Inc. purchased a new stake in shares of Healthpeak Properties in the 4th quarter valued at about $13,681,000. FMR LLC acquired a new position in Healthpeak Properties in the 4th quarter valued at about $14,207,000. Rockefeller Capital Management L.P. acquired a new position in Healthpeak Properties in the 4th quarter valued at about $35,000. Cetera Advisor Networks LLC acquired a new position in Healthpeak Properties in the 4th quarter valued at about $369,000. Finally, Banque Cantonale Vaudoise acquired a new position in Healthpeak Properties in the 4th quarter valued at about $751,000.

Several equities analysts have issued reports on the company. KeyCorp dropped their target price on Healthpeak Properties from $37.00 to $30.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 21st. Barclays reiterated a “buy” rating and set a $28.00 target price on shares of Healthpeak Properties in a research report on Wednesday, April 8th. Wells Fargo & Co dropped their target price on Healthpeak Properties from $35.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Friday, March 27th. Raymond James cut Healthpeak Properties from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 29th. Finally, Citigroup dropped their target price on Healthpeak Properties from $38.00 to $24.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 7th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $28.00.

Shares of PEAK traded down $0.17 on Friday, reaching $26.42. The stock had a trading volume of 45,428 shares, compared to its average volume of 4,713,949. The company’s 50-day moving average is $25.62. Healthpeak Properties has a twelve month low of $18.63 and a twelve month high of $37.93.

Healthpeak Properties (NASDAQ:PEAK) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.44 by $0.10. The firm had revenue of $585.20 million during the quarter, compared to analyst estimates of $531.36 million. The business’s quarterly revenue was up 34.2% on a year-over-year basis.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles.

Featured Story: How mutual funds make money

Want to see what other hedge funds are holding PEAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties (NASDAQ:PEAK).

Institutional Ownership by Quarter for Healthpeak Properties (NASDAQ:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.